Anti-DRG2 antibodies are used in the immunodetection of the protein developmentally regulated GTP binding protein 2. In humans, the canonical protein has a reported length of 364 amino acid residues and a mass of 40.7 kDa. Its subcellular localization is in the nucleus and cytoplasm. It is reported to be highly expressed in skeletal muscle, heart and kidney. A member of the OBG GTPase protein family, DRG2 is known to catalyze the conversion of GTP to GDP through hydrolysis of the gamma-phosphate bond in GTP. Post-translational modifications have been described, including ubiquitination and protein cleavage. Synonyms for this target antigen include TRAFAC GTPase DRG2 and translation factor GTPase DRG2. DRG2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chicken species. A number of DRG2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunofluorescence are also common applications.